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Background: There is no consensus on the role of cortisol in the pathogenesis of obesity 
and metabolic syndrome (MS). This cross-sectional study aimed to analyze the relationship 
of morning plasma cortisol and adrenocorticotropic hormone (ACTH) levels with body mass 
index (BMI) and glucose tolerance.
Subjects and methods: The sample frame was the “Offspring of individuals with diabetes 
study” database. A total of 358 offspring of individuals with type 2 diabetes mellitus (T2DM) 
and 287 individuals without a known family history of T2DM were recruited for the study. 
Subjects who were $10 years of age were selected from the database for analysis. Subjects with 
T2DM were excluded. All participants underwent a 75 g oral glucose tolerance test (OGTT), and 
blood samples were collected at 0, 30, 60, and 120 minutes for glucose, insulin and C-peptide. 
Plasma cortisol, ACTH, and lipid profile were estimated from the fasting sample.
Results: Four hundred and ninety-five participants (305 males [62%] and 190 females [38%]) 
were included in the analysis. ACTH and cortisol levels were higher in normal-weight sub-
jects than in overweight/obese subjects. Both ACTH and cortisol increased as fasting plasma 
glucose increased. Cortisol levels were significantly lower in offspring of T2DM subjects with 
MS than in offspring of T2DM subjects without MS. When adjusted for BMI, the significance 
was marginal. In males, cortisol levels were negatively correlated with early insulin secretion 
during OGTT (insulinogenic index [0–30]) and positively with waist circumference and serum 
high-density lipoprotein cholesterol. In females, fasting glucose and systolic blood pressure 
were significantly and positively correlated.
Conclusion: Body weight was correlated negatively with morning plasma cortisol and ACTH, 
whereas fasting glucose was correlated positively.
Keywords: cortisol and body weight, cortisol and obesity, cortisol and glucose tolerance, 
ACTH, cortisol, metabolic syndrome
Introduction
Central adiposity, hepatic steatosis, dyslipidemia, muscle wasting, pancreatic beta-cell 
dysfunction, and glucose intolerance are features of chronic glucocorticoid excess.1,2 
Many of these features are also observed in patients with prediabetes and metabolic 
syndrome (MS). There is speculation on the possibility of subtle abnormalities of 
cortisol biosynthesis/metabolism in the pathogenesis of MS.3,4 Some reports have 
documented higher plasma cortisol in MS patients than in healthy subjects.5–7 However, 
the relationship between different MS components and serum cortisol is not consistent. 
Some studies have found no association between waist circumference (WC) and cortisol 
in overweight youth,6 whereas others have reported a positive association with WC.8,9 
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The metabolic clearance of cortisol is increased in obese 
individuals which could obscure the underlying positive 
association between plasma cortisol and the features of 
MS.10 Reynolds et al observed higher plasma cortisol in 
glucose-intolerant subjects than in healthy controls.11 Here 
we report our observations from a cross-sectional study on 
morning plasma cortisol and its relationship with obesity 
and glucose tolerance.
Subjects and methods
Our sampling frame was the “Offspring of individuals with 
diabetes study” database.12 There were 358 offspring of 
individuals with type 2 diabetes mellitus (T2DM) and 287 
controls (individuals who did not have a family history of 
T2DM) recruited for the study. The participants were of 
Indian origin with age ranging from 5 to 55 years. Index cases 
with diagnosed T2DM were identified from the endocrine 
clinic of our hospital and their children and grandchildren 
were invited to participate. Subjects who were pregnant, 
lactating, or on medication for any chronic illness were 
excluded. Subjects without a family history of T2DM were 
recruited from the general population and the exclusion 
criteria were the same as above.
From this database, only subjects aged $10 years were 
selected for the analysis (the International Diabetic Federation 
[IDF] criteria for MS are applicable to children $10 years of 
age).13 Subjects who had T2DM were also excluded from the 
analysis. Details of medical history were collected; a physical 
examination including anthropometry was performed. For the 
oral glucose tolerance test (OGTT), subjects were advised to 
have a normal diet and abstain from alcohol for 3 days prior to 
the test. After 10–12 hours of overnight fast, 75 g (1.75 g/kg 
body weight for children, with a maximum dose of 75 g) 
OGTT was performed. Blood samples were collected before 
(timing between 8.45 am and 9.30 am) and at 30, 60, and 
120 minutes after oral glucose. The samples were collected in 
EDTA vials under cold conditions. The fasting sample was used 
for adrenocorticotropic hormone (ACTH), cortisol, and lipid 
profile estimation. Plasma glucose, insulin, and C peptide were 
measured at all time points. Glucose tolerance was classified as 
per American Diabetic Association 2003 criteria.14 Body mass 
index (BMI) of 25 to 29.9 kg/m2 was taken as overweight and 
BMI $30 as obese. For subjects up to 18 years of age, cutoffs 
recommended by the International Obesity Task Force were 
used.15 MS was determined by the IDF criteria.13,16
WC was measured midway between the lowest rib and the 
superior border of the iliac crest with an inelastic   measuring tape. 
The hip circumference was measured at the greatest posterior 
protuberance of buttocks with the subject standing erect, feet 
together. Blood pressure was measured in sitting position in 
the left arm with OMRON electronic apparatus (Omron Health 
Care, Kyoto, Japan), after 10 minutes of rest.
ACTH and cortisol were measured by electro-chemilumi-
nescence assay by ELECSYS 2010 (Roche Diagnostics, IN). 
The intra-assay coefficient of variation (CV) for cortisol was 
3.8% and the inter-assay CV was 4.2%. For ACTH these 
CVs were 7.5% and 8.5%, respectively. Plasma insulin and 
C-peptide were also measured by electro-chemiluminescence 
assay. This assay uses monoclonal antibodies against insulin 
and has 0.05% cross-reactivity with human proinsulin and its 
split forms. Intra-assay CV for insulin was 5.1% and inter-
assay CV was 5.7%. For C-peptide intra-assay CV was 3.9% 
and inter-assay CV was 3.9%.
Plasma glucose was assayed by glucose oxidase method, 
on a Labmate 20 Analyser (Trivitron Diagnostics,   Chennai, 
India). Serum triglycerides (TG) and total cholesterol were 
measured by enzymatic methods. Serum high-density 
lipoprotein (HDL)-cholesterol was measured after precipitation 
of chylomicrons, and very-low-density lipoprotein-cholesterol 
fraction and low-density lipoprotein (LDL) fractions by 
phosphotungstic acid and magnesium chloride. HDL-
cholesterol remains in the supernatant after centrifugation, 
and is measured by the enzymatic cholesterol method. LDL-
cholesterol was calculated from data of the above parameters 
by Friedewald’s equation. Intra-assay CVs for total cholesterol, 
TG, and HDL-cholesterol were 1.9%, 1.9%, and 4.5%, 
respectively, whereas inter-assay CVs were 2.5%, 2.7%, and 
4.9%, respectively. The area under the curve (AUC) during 
the OGTT was calculated according to Tai’s method.17 AUC 
of C-peptide (0–30 minutes) was divided by AUC of glucose 
(0–30 minutes) to determine the insulinogenic index (0–30). 
HOMA-IR (homeostasis model assessment-insulin resistance) 
was measured as proposed by Matthews et al.18
Statistical analysis
Statistical analysis was done using SPSS version15 soft-
ware (Lead Technologies, Lead, US). The continuous data 
were expressed as mean ± SD. Log transformation was also 
applied to skewed data for ACTH, cortisol, insulin, C-peptide, 
HOMA-IR, TG, and insulinogenic index (0–30). Student’s 
unpaired t-test was used to compare two groups. Analysis 
of variance (ANOVA) was used to compare quantitative 
variables when the numbers of groups was .2. General 
linear model was used for comparing groups after adjusting 
for confounding variables. The correlation between morning 
cortisol and other parameters was estimated by Pearson’s 
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correlation method. Partial correlation was performed to 
adjust for confounding variables such as age and BMI. Tests 
were considered significant at P , 0.05.
Results
Six hundred and forty-five subjects participated in the study 
and underwent OGTT. Ten subjects with newly diagnosed 
T2DM were excluded from the analysis; 17 subjects were 
excluded as they were ,10 years of age; 618 subjects fulfilled 
the inclusion criteria; and 495 subjects, for whom complete 
data were available for ACTH and cortisol, were included 
in the analysis. There were 305 (62%) males and 190 (38%) 
females. There were 441 (89%) subjects with normal   glucose 
tolerance, 20 (4%) with impaired fasting glucose, and 34 (7%) 
subjects with impaired glucose tolerance. Three   hundred and 
fifty-eight (72%) subjects were of normal weight, 93 (19%) 
were overweight, and 44 (9%) were obese.
Cortisol and ACTH levels were higher in males (r = -0.09, 
P = 0.04, r = -0.29, P , 0.001, respectively) than in females. 
Morning plasma cortisol and age were positively correlated 
(r = 0.101, P = 0.045). To check the effect of fasting blood 
glucose on morning plasma cortisol, we analyzed cortisol 
levels in different fasting glucose categories in normal and 
overweight subjects. Details are given in Table 1.
There was a rising trend for ACTH and cortisol with 
higher fasting blood glucose irrespective of the body weight 
of subjects. At each fasting glucose category, cortisol levels 
were higher in normal-weight subjects than in overweight 
subjects.
Cortisol levels were significantly higher in subjects with 
impaired fasting glucose (13.8 vs 11.1 ng/mL, P = 0.04) 
than in normal glucose-tolerant (NGT) subjects. Among 
NGT subjects, cortisol and ACTH levels were significantly 
higher in normal-weight subjects than in subjects who were 
overweight (for cortisol 11.4 ± 4.7 vs 10.4 ± 4.4, P = 0.05, 
and for ACTH, 26 ± 21 vs 20 ± 18 pg/mL, P = 0.002).
There were 77 (15.5%) subjects who fulfilled the IDF 
criteria for MS. Among normal-weight subjects there was no 
significant difference in plasma ACTH and cortisol between 
those with and without MS. Among overweight/obese 
  subjects, cortisol levels were lower in those with MS, but did 
not reach statistical significance compared with   overweight/
obese   subjects without MS (9.6 ± 4.3 vs 11 ± 4.9). We 
  performed a subgroup analysis after dividing the subjects into 
four groups, ie, offspring of T2DM subjects with and without 
MS, and negative family history of T2DM with and without 
MS (Table 2). Cortisol levels were significantly lower in sub-
jects with MS and family history of T2DM than in offspring 
of T2DM subjects without MS. When adjusted for BMI, there 
was borderline significance between the groups (P = 0.06).
Correlations of morning plasma cortisol with MS com-
ponents and other cardiovascular risk factors were performed 
separately for males and females. In males, cortisol was 
negatively correlated with WC, fasting insulin, HOMA-IR, 
Table 1 Plasma ACTH and cortisol levels in normal-weight and overweight subjects in different fasting glucose categories
Glucose 0 min 
80 mg/dL
Glucose 0 min 
80.1–90 mg/dL
Glucose 0 min 
90.1–100 mg/dL
Glucose 0 min 
100.1–125 mg/dL
P value
Unadjusted Adjusted for   
age, gender
Normal weight
n 73 176 97 12 – –
Age (years) 21.9 ± 7.8 24.9 ± 8.0 25.9 ± 9.7 31.3 ± 10.1 0.001 –
BMI (kg/m2) 20.1 ± 3.2 20.6 ± 3.1 20.6 ± 2.8 22.7 ± 2.0 0.04 0.500
ACTH (pg/mL) 20.0 ± 15.5 24.5 ± 19.6 33.8 ± 26 31.0 ± 21 ,0.001 0.003
Cortisol (ng/mL) 10.9 ± 4.4 11.3 ± 4.9 12.0 ± 5.0 14.9 ± 4.7 0.050 0.163
Overweight/obese
n 26 55 39 17 –
Age (years) 26.2 ± 10 31.7 ± 11 30.3 ± 11 32.2 ± 11 0.20 –
BMI (kg/m2) 28.1 ± 2.6 28.7 ± 3.3 29.9 ± 5.0 29.6 ± 4.3 0.30 –
ACTH (pg/mL) 16.6 ± 15 19.0 ± 19 24.3 ± 18 23.1 ± 13 0.14 0.32
Cortisol (ng/mL) 10.1 ± 4.5 10.4 ± 4.6 10.7 ± 5.0 10.9 ± 4.9 0.80 0.79
Overall
n 99 231 136 29 –
Age (years) 23.0 ± 8.7 26.6 ± 9.6 27 ± 10.3 31.9 ± 10.7 ,0.001 –
BMI (kg/m2) 22.2 ± 4.7 22.6 ± 4.7 23.4 ± 5.5 26.8 ± 4.9 ,0.001 –
ACTH (pg/mL) 19.1 ± 15 23.2 ± 20 31.1 ± 24.5 26.3 ± 17 ,0.001 0.001
Cortisol (ng/mL) 10.7 ± 4.4 11.1 ± 4.8 11.6 ± 5.1 12.6 ± 5.2 0.236 0.434
Abbreviations: ACTH, adrenocorticotropic hormone; BMI, body mass index.
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insulinogenic index (0–30, IGI 30), and positively correlated 
with HDL-cholesterol. After adjusting for BMI, cortisol was 
positively correlated with HDL-cholesterol and negatively 
correlated with IGI 30. In females, cortisol was positively cor-
related with fasting glucose and systolic blood pressure. The 
significance persisted even after adjusting for BMI (Table 3).
In males, after adjusting for age and BMI, ACTH levels 
positively correlated with fasting glucose (r = 0.15, P = 0.02) 
and HDL-cholesterol (r = 0.13, P = 0.03) and negatively cor-
related with IGI 30 (r = -0.149, P = 0.02). In females, ACTH 
was correlated with fasting glucose (r = 0.22, P = 0.002) and 
systolic (r = 0.17, P = 0.02) and diastolic blood pressure 
(r = 0.27, P , 0.001).
Discussion
We observed opposing effects of obesity and fasting glucose 
on morning plasma cortisol levels. Cortisol was lower in 
obese than normal-weight subjects in each fasting glucose 
category. In normal-weight MS subjects, cortisol levels were 
similar to those of normal-weight controls, but obese MS 
subjects had lower cortisol. Subjects with MS and a family 
history of T2DM had significantly lower cortisol and higher 
BMI. There was gender-specific association of morning cor-
tisol with MS components. In males, cortisol was positively 
correlated with HDL-cholesterol and negatively with WC and 
IGI 30. In females, cortisol levels were positively correlated 
with systolic blood pressure and fasting glucose.
Anagnostis et al observed that patients with MS showed 
hyperactivity of the hypothalamic–pituitary–adrenal (HPA) 
axis, which lead to a state of “functional hypercortisolism.”4 
The cause of this activation of the HPA axis remains 
uncertain; it could be related to chronic stress, low birth 
weight, or a variety of other factors.4 Reinehr and Andler 
observed that cortisol levels were moderately elevated in 
Table 2 Plasma ACTH and cortisol levels in subjects with and without MS in positive and negative family history of T2DM categories
Subjects with family history of T2DM Subjects without family history of T2DM
MS No MS P value MS No MS P value
n 50 228 – 27 190 –
Males (%) 27 (54) 133 (58) 0.575 19 (70) 126 (66) 0.675
Age 35.2 ± 10.5 21.8 ± 8.6 ,0.001 34.2 ± 8.2 28.3 ± 8.5 0.001
BMI 28.9 ± 4.37 22.4 ± 5.3 ,0.001 25.4 ± 2.4 21.6 ± 3.5 ,0.001
ACTHa 19.7 ± 13.9 23.7 ± 20 0.211 29.0 ± 23 26.5 ± 22.2 0.840
Cortisola 9.6 ± 4.2 11.1 ± 4.8 0.045 11.3 ± 4.8 11.8 ± 5.0 0.423
Note: aData adjusted for age and gender. 
Abbreviations: ACTH, adrenocorticotropic hormone; BMI, body mass index; MS, metabolic syndrome; T2DM, type 2 diabetes mellitus.
Table 3 Correlation of morning cortisol with metabolic syndrome-related risk factors in males and females
Males 
n = 305
Females 
n = 190
Adjusted for age Adjusted for age  
and BMI
Adjusted for age Adjusted for age 
and BMI
r value P value r value P value r value P value r value P value
WC (cm) -0.12 0.03* -0.05 0.46
Waist to hip ratio -0.07 0.2 0.02 0.76 -0.06 0.25 -0.06 0.38
Fasting insulin (μIU/mL) -0.139 0.015* -0.04 0.45 -0.02 0.81 -0.01 0.84
Fasting glucose (mg/dL) -0.003 0.95 0.02 0.71 0.15 0.04* 0.15 0.03*
HOMA-IR (μU/mL, mmol/l) -0.133 0.02* -0.04 0.50 0.01 0.94 0.01 0.83
IGI 30 (nmol/mmol) -0.198 0.001 -0.156 0.009* 0.02 0.78 0.02 0.78
TG (mg/dL) 0.061 0.29 0.11 0.06 -0.01 0.84 -0.01 0.86
Total cholesterol (mg/dL) 0.054 0.35 0.09 0.09 0.10 0.15 0.10 0.14
HDL-cholesterol (mg/dL) 0.149 0.01* 0.12 0.04* 0.09 0.19 0.10 0.17
LDL-cholesterol (mg/dL) -0.012 0.82 0.02 0.71 0.09 0.21 0.09 0.21
Systolic BP (mmHg) -0.04 0.52 0.01 0.76 0.15 0.05* 0.15 0.04*
Diastolic BP (mmHg) -0.04 0.52 0.02 0.66 0.12 0.11 0.12 0.11
Note: *Significant P , 0.05. 
Abbreviations:  ACTH,  adrenocorticotropic  hormone;  BMI,  body  mass  index;  BP,  blood  pressure;  HOMA-IR,  homeostasis  model  assessment-insulin  resistance;   
IGI 30, insulinogenic index (0-30); HDL-cholesterol, high-density lipoprotein cholesterol; LDL-cholesterol, low-density lipoprotein cholesterol; MS, metabolic syndrome; 
T2DM, type 2 diabetes mellitus; TG, triglycerides; WC, waist circumference.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
350
Praveen et alDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4
obese insulin-resistant subjects. A reduction in cortisol 
with weight loss has been reported.19 Our observation of 
lower plasma cortisol in obese subjects is in agreement with 
that of Travison et al who observed lower plasma cortisol 
in obese subjects than in lean subjects.20 Phillips et al also 
observed higher plasma cortisol concentrations associated 
with older age and lower BMI, in 50- to 70-year-old men.21 
Higher systolic blood pressure, fasting glucose, and fasting 
TG concentrations and insulin resistance were also related to 
higher cortisol.21 Weigensberg et al observed higher morning 
serum cortisol in overweight Latino youths with MS. Sub-
jects with impaired fasting glucose had significantly higher 
morning cortisol than those with normal fasting glucose. 
They found no relationship between cortisol and WC.6 Ward 
et al, in a study conducted on a South Indian population, 
reported that high fasting cortisol levels were significantly 
associated with components of MS such as fasting glucose, 
systolic and diastolic blood pressure, insulin resistance, and 
fasting TG levels.22
The MONICA (Monitoring of Trends and Determinants 
in Cardiovascular Disease) study in northern Sweden showed 
that increasing obesity and plasma cortisol make independent 
and gender-specific contributions to variations in blood pres-
sure and other cardiovascular risk factors.23 It was observed 
that the association of plasma cortisol with blood pressure 
was stronger in men and the association with other features 
such as hyperinsulinemia and hypertriglyceridemia was 
stronger in women.23 However, we did not observe such a 
pattern. We observed stronger correlation of cortisol with 
serum TG and fasting insulin in men and between cortisol 
and systolic blood pressure in women.
The cause–effect relationship of obesity and cortisol is 
not clearly known. Studies that used a 24-hour urine cortisol 
or stimulated cortisol measurement have reported higher 
cortisol secretion in obesity.24,25 This may be due to an altered 
HPA axis in obesity, resulting in a blunted diurnal variation 
in cortisol levels, with lower morning cortisol and higher 
evening cortisol.26 Another explanation of lower morning 
cortisol could be the enhanced metabolic clearance of cortisol 
in obesity, which is compensated for only partly by enhanced 
cortisol secretion.10
The main limitation of the present study is that it is a 
single morning cortisol measurement. The cause–effect 
relationship of cortisol with obesity and other related 
parameters cannot be deduced from a cross-sectional study. 
In summary, we observed opposing effects of obesity 
and fasting plasma glucose on morning plasma cortisol. 
Obese subjects had lower morning plasma cortisol than 
lean subjects. Subjects with impaired fasting glucose had 
higher morning plasma cortisol than subjects with normal 
fasting glucose.
Acknowledgments
We acknowledge the help of Shiji Binu and Leslie James 
for their assistance in performing hormonal assays. Manoj 
Srivasthava is acknowledged for his help in recruiting par-
ticipants for the study. The study was funded by the Indian 
Council of Medical Research.
Disclosure
The authors declare no conflicts of interest in relation to 
this paper.
References
  1.  van Raalte DH, Ouwens DM, Diamant M. Novel insights into 
glucocorticoid-mediated diabetogenic effects: towards expansion of 
therapeutic options? Eur J Clin Invest. 2009;39(2):81–93.
  2.  Purnell JQ, Kahn SE, Samuels MH, Brandon D, Loriaux DL, 
  Brunzell JD. Enhanced cortisol production rates, free cortisol, and 
11beta-HSD-1 expression correlate with visceral fat and insulin 
  resistance in men: effect of weight loss. Am J Physiol Endocrinol Metab. 
2009;296(2):E351–E357.
  3.  Walker BR. Cortisol–cause and cure for metabolic syndrome? Diabet 
Med. 2006;23(12):1281–1288.
  4.  Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. 
Clinical review: The pathogenetic role of cortisol in the metabolic 
syndrome: a hypothesis. J Clin Endocrinol Metab. 2009;94(8): 
2692–2701.
  5.  Sen Y, Aygun D, Yilmaz E, Ayar A. Children and adolescents with 
obesity and the metabolic syndrome have high circulating cortisol levels. 
Neuro Endocrinol Lett. 2008;29(1):141–145.
  6.  Weigensberg MJ, Toledo-Corral CM, Goran MI. Association between 
the metabolic syndrome and serum cortisol in overweight Latino youth. 
J Clin Endocrinol Metab. 2008;93(4):1372–1378.
  7.  Duclos M, Marquez Pereira P, Barat P, Gatta B, Roger P. Increased 
cortisol bioavailability, abdominal obesity, and the metabolic syndrome 
in obese women. Obes Res. 2005;13(7):1157–1166.
  8.  Rosmond R, Dallman MF, Björntorp P. Stress-related cortisol secre-
tion in men: relationships with abdominal obesity and endocrine, 
metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab. 
1998;83(6):1853–1859.
  9.  Epel ES, McEwen B, Seeman T, et al. Stress and body shape: stress-
induced cortisol secretion is consistently greater among women with 
central fat. Psychosom Med. 2000;62(5):623–632.
  10.  Andrew R, Phillips DI, Walker BR. Obesity and gender influence 
cortisol secretion and metabolism in man. J Clin Endocrinol Metab. 
1998;83(5):1806–1809.
  11.  Reynolds RM, Walker BR, Syddall HE, Whorwood CB, Wood PJ, 
Phillips DI. Elevated plasma cortisol in glucose-intolerant men: 
  differences in responses to glucose and habituation to venepuncture.   
J Clin Endocrinol Metab. 2001;86(3):1149–1153.
  12.  Praveen EP, Kulshreshtha B, Khurana ML, et al. Obesity and metabolic 
abnormalities in offspring of subjects with diabetes mellitus. Diabetes 
Technol Ther. 2010;12(9):723–730.
  13.  Zimmet P, Alberti G, Kaufman F, et al; International Diabetes 
  Federation Task Force on Epidemiology and Prevention of Diabetes. 
The metabolic syndrome in children and adolescents. Lancet. 2007; 
369(9598):2059–2061.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
351
Morning plasma cortisolDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is 
an international, peer-reviewed open-access journal committed to 
the rapid publication of the latest laboratory and clinical findings 
in the fields of diabetes, metabolic syndrome and obesity research.   
Original research, review, case reports, hypothesis formation, expert 
opinion and commentaries are all considered for publication. The 
manuscript management system is completely online and includes a 
very quick and fair peer-review system, which is all easy to use. Visit 
http://www.dovepress.com/testimonials.php to read real quotes from 
published authors.
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4
  14.  Diagnosis and classification of diabetes mellitus. Diabetes Care. 
2004;27(Suppl 1):S5–S10.
  15.  Cole T J, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard 
definition for child overweight and obesity worldwide: International 
survey. BMJ. 2000;320(7244):1240–1243.
  16.  Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force 
  Consensus Group. The metabolic syndrome – a new worldwide 
definition. Lancet. 2005;366(9491):1059–1062.
  17.  Tai MM. A mathematical model for the determination of total area 
under glucose tolerance and other metabolic curves. Diabetes Care. 
1994;17(2):152–154.
  18.  Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, 
Turner RC. Homeostasis model assessment: insulin resistance and beta-
cell function from fasting plasma glucose and insulin concentrations in 
man. Diabetologia. 1985;28(7):412–419.
  19.  Reinehr T, Andler W. Cortisol and its relation to insulin resistance 
before and after weight loss in obese children. Horm Res. 2004; 
62(3):107–112.
  20.  Travison TG, O’Donnell AB, Araujo AB, Matsumoto AM, McKinlay JB. 
Cortisol levels and measures of body composition in middle-aged and 
older men. Clin Endocrinol (Oxf). 2007;67(1):71–77.
  21.  Phillips DI, Barker DJ, Fall CH, et al. Elevated plasma cortisol 
  concentrations: a link between low birth weight and the insulin resistance 
syndrome? J Clin Endocrinol Metab. 1998;83(3):757–760.
  22.  Ward AM, Fall CH, Stein CE, et al. Cortisol and the metabolic syndrome 
in South Asians. Clin Endocrinol (Oxf). 2003;58(4):500–505.
  23.  Walker BR, Soderberg S, Lindahl B, Olsson T. Independent effects of 
obesity and cortisol in predicting cardiovascular risk factors in men and 
women. J Intern Med. 2000;247(2):198–204.
  24.  Strain GW, Zumoff B, Kream J, Strain JJ, Levin J, Fukushima D. 
Sex difference in the influence of obesity on the 24 hr mean plasma 
concentration of cortisol. Metabolism. 1982;31(3):209–212.
  25.  Pasquali R, Cantobelli S, Casimirri F, et al. The hypothalamic-
  pituitary-adrenal axis in obese women with different patterns of body 
fat distribution. J Clin Endocrinol Metab. 1993;77(2):341–346.
  26.  Rosmond R, Dallman MF, Björntorp P. Stress-related cortisol secre-
tion in men: relationships with abdominal obesity and endocrine, 
metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab. 
1998;83(6):1853–1859.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
352
Praveen et al